Home 2023

Acute lymphoblastic leukemia

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
Redefining Hyperdiploid Leukemia
Cancer

Redefining Hyperdiploid Leukemia

Christina Jackson -
0
Stem Cells and Reprogramming in Human Acute Leukemia
Cancer

Stem Cells and Reprogramming in Human Acute Leukemia

Kathy Vuksanaj -
21
Potential Novel Strategy against T-Cell Acute Lymphoblastic Leukemia
Cancer

Potential Novel Strategy against T-Cell Acute Lymphoblastic Leukemia

Christina Jackson -
0
Drug-Resistant Acute Lymphoblastic Leukemia and Relapse May Be Caused by Thiopurines
Cancer

Drug-Resistant Acute Lymphoblastic Leukemia and Relapse May Be Caused by Thiopurines

Christina Jackson -
0
Gene Therapy Dollar Is Waiting on Viral Vector Dime
Bioprocessing

Gene Therapy Dollar Is Waiting on Viral Vector Dime

Kathy Vuksanaj -
0
Opportunities and Challenges in Cell and Gene Therapy Development*
Insights

Opportunities and Challenges in Cell and Gene Therapy Development*

Kathy Vuksanaj -
0
Cell Therapy Manufacturing Tries “Building the Plane While Flying It”
Bioprocessing

Cell Therapy Manufacturing Tries “Building the Plane While Flying It”

Gareth John Macdonald -
0
Gene Therapy Vectors Deliver to More Places Than Once Thought
Genome Editing

Gene Therapy Vectors Deliver to More Places Than Once Thought

Kevin Mayer -
0
Crafting a More Efficient CAR T-Cell Industry
Insights

Crafting a More Efficient CAR T-Cell Industry

Vivienne Raper, PhD -
0
123...5Page 1 of 5
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.